Purchase Order HT942523P0054
- Not listed
- This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company that specializes in forensic genomics and DNA sequencing. The contract is for the provision of a MiSeQ FGX Sequencing System, with a potential value of $407,480.22. Verogen has previously provided reagents, consumables, sequencing systems, and technical services to support DNA analysis at various federal agencies, including the Defense Health Agency, FBI,...
- This is a firm fixed price contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company that specializes in forensic genomics and DNA sequencing. The contract has a potential value of $235,984.48 and does not have a set-aside designation. Through this contract, Verogen will provide the Defense Health Agency with various products and services related to next-generation DNA sequencing, including MiSeq FGx sequencing systems, ForenSeq reagent kits, sequencing...
- This is a federal contract award to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The award, valued at $93,198.80, was issued by the Defense Health Agency (DHA) and provides for the procurement of Illumina reagents and consumables through a Blanket Purchase Agreement (BPA) call. The contract does not have a small business set-aside designation. Verogen, as the prime contractor, will supply the DHA with its MiSeq FGx sequencing systems, ForenSeq...
- This is a firm fixed price contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. The contract, valued at $165,692.52, is for the delivery of 180 units of the MiSeq RGT KIT. Verogen has previously provided sequencing systems, reagents, consumables, and technical services to support DNA analysis at various federal agencies, including the Defense Health Agency, FBI, Army Criminal Investigation...
- This is a firm fixed-price contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. The contract, valued at $413,414.01, is for the provision of MiSeQ RGT V3 sequencing systems, reagents, consumables, and technical support services. The contract is a Blanket Purchase Agreement (BPA) call, which allows the agency to procure standardized laboratory supplies to support its genomic sequencing programs....
- This federal contract award was issued by the Defense Health Agency to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. The $92,962.80 Firm Fixed Price contract is for the delivery of MiSeq Reagent Kits (150 Cycle) under a Blanket Purchase Agreement call. The contract has no set-aside designation and was awarded on December 13, 2018 with a completion date of January 4, 2019. Verogen is an experienced prime contractor and subcontractor that has...
- The U.S. Department of the Army Criminal Investigation Command awarded a firm fixed price purchase order to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. The $187,389.00 contract is for the provision of an MISEQ FGX UPGRADE KIT, to be completed by July 31, 2022. Verogen has previously provided sequencing systems, reagents, consumables, and technical services to support DNA analysis at various federal agencies, including the Defense Health...
- This federal contract award was made by the Defense Health Agency to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The $82,836.24 contract, awarded on November 22, 2019, is a Blanket Purchase Agreement (BPA) call for the procurement of MiSeq RGT KIT V2 reagents and consumables. The contract has a firm fixed price and an ultimate completion date of November 27, 2019. Verogen, the prime contractor, has supported various federal agencies such as the...
- This is a firm fixed price contract awarded by the Defense Health Agency (DHA) to Verogen, Inc., a biotechnology company that specializes in forensic genomics and DNA sequencing. The contract is for the delivery of 200 units of the MiSeq RGT KT V3 (150) reagent kit, valued at $237,552.00. Verogen has provided similar sequencing systems, reagents, and technical services to federal agencies like the FBI, Army Criminal Investigation Command, and National Institute of Standards and Technology...
- This contract was awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. The $262,429.92 firm fixed price contract is for the delivery of MiSeq FGx sequencing systems, ForenSeq reagent kits, next-generation sequencing reagents and consumables, and technical support services. This contract is a blanket purchase agreement, which facilitates the procurement of standardized laboratory supplies to support the...
This federal contract award to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing, is for the provision of a MiSeq FGX Sequencing System. The $488,081.58 firm fixed-price purchase order was awarded by the Defense Health Agency, a defense agency, on June 22, 2023, with a completion date of September 1, 2023. The contract does not have a small business set-aside designation. Verogen, Inc. has previously supported DNA analysis programs for various federal agencies, including the Defense Health Agency, Federal Bureau of Investigation, U.S. Army Criminal Investigation Command, and National Institute of Standards and Technology, through the delivery of DNA sequencing systems, reagent kits, and technical support services. This award is part of a larger Indefinite Delivery Vehicle (IDV) contract in the form of a single-award Blanket Purchase Agreement (BPA) with the Defense Health Agency, valued at $7,433,000, which allows for the procurement of reagents and consumables through October 31, 2028 to support the agency's genomic sequencing initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $488.1k | 6/22/23 |